Literature DB >> 1115421

Experimentally induced infection of dogs, cats, and nonhuman primates with Ehrlichia equi, etiologic agent of equine ehrlichiosis.

G E Lewis, D L Huxsoll, M Ristic, A J Johnson.   

Abstract

Dogs (German Shepherd Dogs and Beagles), cates, rhesus macaques (Macaca mulatta), and baboons (Papio anubis) were inoculated with Whrlichia equi, the etiologic agent of equine ehrlichiosis. Within 3 to 7 days after inoculation, morulae were observed in the eosinophils of cats, neurtrophils of macaques and baboons, and in both neutrophils and eosinophils of dogs. The severe disease produced in horses by this agent was not a feature of E equi infection in dogs, cats, macaques, and baboons. However, a susceptible horse, inoculated with the pooled blood of 2 infected macaques, developed severe clinical signs of equine ehrlichiosis. Infection with E equi did not alter the susceptibiltiy of dogs to infection with Ehrlichia canis and did not prevent development of signs of disease resulting from this infection. The broad experimental host range from this infection. The broad experimental host range of E equi distinguishes it from other ehrlichial agents which are characterized by a rather narrow host range. The susceptibiltiy of nonhuman primates to infection with E equi provides a basis for consideration of the potential transmission of ehrlichial agents to man.

Entities:  

Mesh:

Year:  1975        PMID: 1115421

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  23 in total

1.  Granulocytic ehrlichiosis in two dogs in Switzerland.

Authors:  N Pusterla; J Huder; C Wolfensberger; B Litschi; A Parvis; H Lutz
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Anaplasma phagocytophilum infection in a domestic cat in Finland: Case report.

Authors:  Helka M Heikkilä; Anna Bondarenko; Andrea Mihalkov; Kurt Pfister; Thomas Spillmann
Journal:  Acta Vet Scand       Date:  2010-11-15       Impact factor: 1.695

3.  Ultrastructural observations on Ehrlichia equi organisms in equine granulocytes.

Authors:  D M Sells; P K Hildebrandt; G E Lewis; M B Nyindo; M Ristic
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

4.  Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture.

Authors:  U G Munderloh; J E Madigan; J S Dumler; J L Goodman; S F Hayes; J E Barlough; C M Nelson; T J Kurtti
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

5.  A case of Ehrlichia equi in an adult horse in British Columbia.

Authors:  A Berrington; R Moats; S Lester
Journal:  Can Vet J       Date:  1996-03       Impact factor: 1.008

6.  Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolates from Northern California.

Authors:  J S Chae; J E Foley; J S Dumler; J E Madigan
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

7.  Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.

Authors:  J S Dumler; K M Asanovich; J S Bakken; P Richter; R Kimsey; J E Madigan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Naturally occurring Ehrlichia chaffeensis infection in two prosimian primate species: ring-tailed lemurs (Lemur catta) and ruffed lemurs (Varecia variegata).

Authors:  Cathy V Williams; Jan L Van Steenhouse; Julie M Bradley; Susan I Hancock; Barbara C Hegarty; Edward B Breitschwerdt
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.